Parthenolide (PN) is the principal sesquiterpene lactone in feverfew (Tanacetum parthenium) with proven antiinflammatory properties. We have previously reported that PN possesses strong anticancer activity in ultraviolet B (UVB)-induced skin cancer in SKH-1 hairless mice. In order to further understand the mechanism(s) involved in the anticancer activity of PN, we investigated the role of protein kinase C (PKC) in the sensitization activity of PN on UVB-induced apoptosis. Several subtypes of PKC have been reported to be involved in UVB-induced signaling cascade with both pro-and anti-apoptotic activities. Here we focused on two isoforms of PKC: novel PKCd and atypical PKCz. In JB6 murine epidermal cells, UVB induces the membrane translocations of both PKCs, and PN pre-treatment enhances the membrane translocation of PKCd, but inhibits the translocation of PKCz. Similar results were also detected when the activities of these PKCs were tested with the PKC kinase assay. Moreover, pre-treatment with a specific PKCd inhibitor, rotterlin, completely diminishes the sensitization effect of PN on UVB-induced apoptosis. When cells were transiently transfected with dominant negative PKCd or wild-type PKCz, the sensitization effect of PN on UVB-induced apoptosis was also drastically reduced. Further mechanistic study revealed that PKCz, but not PKCd, is required for UVBinduced p38 MAPK activation and PN is likely to act through PKCz to suppress p38 activation in UVB-treated JB6 cells. In conclusion, we demonstrated that PN sensitizes UVB-induced apoptosis via PKC-dependent pathways.
Introduction
Feverfew (Tanacetum parthenium) has been used as a herbal plant for centuries in Europe, with known anti-microbial and anti-inflammatory properties (1, 2) . Parthenolide (PN), a sesquiterpene lactone, is one of the principal bioactive components of this plant. It is believed that the bioactivity of PN is mediated via the highly electrophilic a-methylene-g-lactone ring and an epoxide residue which are capable of interacting rapidly with nucleophilic sites of biological molecules (3, 4) . PN is a potent inhibitor of DNA synthesis and cell proliferation in a number of cancer cell lines (5) (6) (7) . In addition, PN has been reported to induce apoptosis via caspase activation and mitochondria dysfunction (8) , disruption in intracellular thiols and calcium equilibrium (9) , as well as activation of pro-apoptotic Bcl-2 family proteins (10) . On the other hand, PN also has been shown to sensitize cells to apoptosis induced by various stimuli such as ultraviolet B (UVB), tumor necrosis factor-a (TNF-a) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), presumably through its action on activator protein-1 (AP-1) signaling pathway (11) (12) (13) . The in vivo anticancer activity of PN has been studied recently. For instance, we have demonstrated that PN possesses a strong chemopreventive property against UVB-induced skin cancer in SKH-1 hairless mice (12) , whereas Sweeney et al. (14) revealed that PN in combination with docetaxel is capable of reducing metastasis and improving survival in the xenograft model of breast cancer.
The electromagnetic spectrum of ultraviolet (UV) can be grouped into UVA (320-400 nm), UVB (280-320 nm) and UVC (200-280 nm). UVB exposure is the main etiological factor for non-melanoma skin cancer in human (15) . The mechanism(s) of UVB-induced skin cancer have not been fully understood. Several transcriptional factors including AP-1, nuclear transcription factor-kappa B (NF-kB), nuclear factor of activated T cells (NF-AT), and signal transducers and activators of transcription have been linked to the tumorpromoting ability of UVB (16) (17) (18) (19) .
Protein kinase C (PKC) is a group of serine/threonine kinases that regulate many cellular functions such as proliferation, differentiation, transformation, survival and apoptosis (20) . PKC can be classified into three groups based on the co-factors required for activation: (i) the Ca 2þ and diacylglycerol (DAG)-dependent classical or conventional PKC that consists of isotypes a, b1, b2 and g; (ii) the DAG-dependent, Ca 2þ -independent novel PKC that consist of d, h, e and u; and (iii) the DAG-and Ca 2þ -independent atypical PKC that consist of i/l and z. The consequences of PKC activation by UVB is rather cell-type specific and could lead to inhibition on cell proliferation or even induction of apoptosis. Among all, PKCd seems to be the main PKC subtype with pro-apoptotic functions in response to various extracellular stimuli including UVB (21, 22) , whereas PKCz has been shown to be antiapoptotic in response to UV (23, 24) .
Our previous findings (12) showed that the suppression of mitogen activated protein kinase (MAPK) and AP-1 signaling cascade by PN contributes to its sensitization effect on UVBinduced apoptosis in JB6 cells. It is also known that certain subtypes of PKC regulate the MAPK-AP-1 pathway in UVBtreated cells (21, 25) . Hence, the main objective of this study is to explore the involvement of PKC to further understand the underlying mechanism(s) of the chemopreventive property of PN. Our data demonstrated here that PN selectively inhibits UVB-induced PKCz activation and subsequent p38 MAPK activation, while further enhancing UVB-induced PKCd activity; both contribute to the sensitization effect of PN on UVB-induced apoptosis in murine epidermal JB6 cells.
Materials and methods
Chemicals and reagents PN (97% pure) was purchased from Biomol (Plymouth Meeting, PA). Anti-HA, PKC-d and z polyclonal antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA). Secondary antibodies (horseradish peroxidase conjugated goat anti-rabbit IgG and goat anti-mouse IgG) and enhanced chemiluminescence substrate were from Pierce (Rockford, IL). g-p32 ATP was obtained from Perkin-Elmer (Boston, MA). PKC inhibitors GF109203X and rotterlin were purchased from Calbiochem (San Diego, CA). Other common chemicals were from Sigma-Aldrich (St Louis, MO).
Cell culture and UVB exposure JB6 murine epidermal cells were cultured in minimum essential medium (MEM) supplemented with 5% fetal bovine serum (FBS) and 100 U/ml penicillin, and 100 mg/ml streptomycin at 37 C in 5% CO 2 /air atmosphere as described previously (12) . Cells were seeded in 60 mm cultural dishes and starved with MEM containing 0.5% FBS for 24 h after reaching 80% confluence. After pre-treatment with various reagents at designated conditions, cells were washed with PBS once and then exposed to UVB in fresh PBS. UVB was delivered through a bank of FS24 lamps (Light Sources, Orange, CT) with spectral irradiance of 280-400 nm, 80% of which was in the UVB region (280-320 nm) with a peak at $313 nm. The emitted UVB dose was quantified using a phototherapy radiometer (International Light, Newburyport, MA) equipped with IL SED 240 detector. Cells were returned to the incubator with the addition of the previous culture medium until the time of collection.
Transient transfection
Wild-type and dominant negative (DN) PKCd and PKCz plasmids were kindly provided by Dr J.W.Soh from Inha University, Incheon, Korea. DN-p38a and DN-p38b 2 plasmids were gifts from Dr J.Han (Scripps Research Institute, La Jolla, CA, USA). Cells were co-transfected with designated PKC plasmids and a transfection marker pDsRed (Clontech, Palo Alto, CA) using LipofectAMINE reagent (Invitrogen, Carlsbad, CA) according to manufacturer's protocol. Cells were subjected to various treatments 24 h after transfection.
Detection of apoptotic cell death
Following the designated treatments, apoptotic cell death was quantified using DNA content analysis (sub-G1 cells) as described previously (26) . In some experiments, cells were first transiently transfected with various PKC plasmids and pDsRed. Apoptotic cell death was then determined using DNA content analysis coupled with flow cytometry after 4 0 ,6-diamidino-2-phenylindole (DAPI) staining. Briefly, cells were washed with phosphate buffered saline (PBS), fixed first with 0.5% para-formaldehyde and then with 70% ethanol. After staining with DAPI, 20 000 cells from each group were analyzed by flow cytometry using Becton Dickinson FACSVantage SE system (Franklin Lakes, NJ) (27) . Only those transfected cells with expression of the red fluorescence protein were then gated for analyzing the percentage of sub-G1 cells using WinMDI 2.7 software (Scripps Institute, La Jolla, CA).
PKC translocation assay PKC translocation assay was performed based on a published method (21) with modifications. In brief, 15 min after UVB irradiation cells were washed once with ice-cold PBS and then sonicated in homogenization buffer A [20 mM Tris-HCl (pH 8.0), 10 mM EGTA, 2 mM EDTA, 2 mM DTT, 1 mM PMSF and protease inhibitor cocktail] for 10 s on ice. The lysate was then centrifuged at 100 000 g for 1 h at 4 C. The supernatant was collected as the cytosolic fraction. The pellet was then resuspended in homogenization buffer B (with 1% Triton X-100 in buffer A) and sonicated for another 10 s on ice. The suspension was centrifuged at 15 000 g for 15 min at 4 C. The supernatant was collected as the membrane fraction. Using 8% SDS-polyacrylamide gel 30 mg of proteins were separated in Mini-Protein II system (Bio-Rad, Hercules, CA). Following electrophoresis the protein was transferred to a PVDF membrane (Millipore, Bedford, MA) and subsequently hybridized with anti-PKCd and anti-PKCz antibodies. The blots were detected using the enhanced chemiluminescence method (Pierce). The blots were scanned using Kodak Image Station (New Haven, CT) and the densitometric measurements of the bands were performed using Kodak 1D 3.5 software.
PKC kinase assay PKC kinase assay was performed according to a published method (28) with modifications. Briefly, cells were harvested 30 min after UVB irradiation in PKC lysis buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 0.1% Tween-20, 1 mM EDTA, 2.5 mM EGTA, 10% glycerol, 0.1 mM PMSF, 1 mM NaF, 0.1 mM Na 3 VO 4 , 10 mM b-glycerophosphate and protease inhibitor cocktail]. The cell lysate was then centrifuged at 12 000 g for 15 min at 4 C and the supernatant was collected as cellular protein. Four hundred micrograms of protein were immunoprecipitated with anti-PKC antibodies (4 mg) overnight and followed by incubation with protein G-sepharose for 1 h. The immunoprecipitates were washed five times with ice-cold kinase buffer [50 mM HEPES (pH 7.5), 10 mM MgCl 2 , 1 mM DTT, 2.5 mM EGTA, 1 mM NaF, 0.1 mM Na 3 VO 4 and 10 mM b-glycerophosphate]. The kinase assay was initiated by adding 30 ml of kinase buffer containing 10 mg of GST-MARCKS substrate, 0.5 mCi of [g- 32 P]ATP and protease inhibitor cocktail. The reaction were performed for 30 min at 30 C and was terminated by adding 3Â sampler buffer. All reaction mixes were then boiled for 5 min before being separated on 10% SDS-polyacrylamide gel in Mini-Protein II system (Bio-Rad). Gels were then dried and exposed to an X-ray film (Kodak) at room temperature.
Statistical analysis
All numeric data are presented as mean AE standard deviations (SD) from at least three independent experiments and analyzed using one-way ANOVA with Student-Newman-Keul as post hoc comparison. A P-value 5 0.05 is considered as statistically significant.
Results

PN sensitizes UVB-induced apoptosis via PKC-dependent pathways
Our previous findings demonstrated that PN is capable of sensitizing JB6 cells to UVB-induced apoptosis via the MAPK-AP-1 signaling pathway (12) . It is known that UVB activates PKC, and PKC regulates the MAPK-AP-1 signaling pathway (29) . Here we first investigated if PKC plays a role in PN-sensitized UVB-induced apoptosis by using 2 PKC inhibitors. As shown in Figure 1A , pre-treatment with GF109203X, a pan-PKC inhibitor also sensitizes cells to UVB-induced apoptosis, although to a lesser extent than PN. In contrast, pretreatment with a specific PKCd inhibitor, rotterlin, is capable of completely protecting cells from apoptosis induced by UVB alone or PN plus UVB ( Figure 1B ). Data from this study thus suggested that PKCd is critical in both UVB and PN-UVBinduced apoptosis, consistent with some of the earlier reports that PKCd possesses mainly pro-apoptotic functions in response to various extracellular stimuli (21, 22) .
PN selectively regulates different isoforms of PKC in UVB-induced activations UVB is known to activate certain subtypes of PKC such as PKCd and PKCz (21, 23) . One of the critical events of PKC activation is the translocation from the cytosol to membrane (30) . In this study, we first measured UVB-induced PKC activation by determining PKC membrane translocation. Figure 2 provides convincing evidence that UVB-induced membrane translocations of PKCd and PKCz 15 min postirradiation in JB6 cells. Similar changes were also observed in other PKC isoforms such as PKCh and PKCl (data not shown). When cells were pre-treated with 5 mM of PN, the UVB-induced translocation of PKCz was significantly inhibited ( Figure 2B ) while the translocation of PKCd was further enhanced (Figure 2A) . A consistent pattern of changes was also detected when the activation of PKC was measured using the in vitro PKC kinase assay: PN inhibited the UVB-induced activation of PKCz ( Figure 3B ) while further enhancing that of PKCd ( Figure 3A) .
In order to further understand the differential roles of PKC isoforms on the sensitization effect of PN on UVB-induced apoptosis, cells were transiently transfected with wild-type or DN forms of PKCd or PKCz plasmids, together with pDsRed
as the transfection marker, followed by PN-UVB treatment. When the morphological changes of apoptotic cell death were examined under an inverted fluorescence microscope, it was found that the DN-PKCd transfected cells became rather resistant to PN-UVB-induced apoptosis whereas the wild-type PKCd transfected cells underwent massive apoptosis upon PN-UVB treatment (Figure 4) . On the contrary, overexpression of wild-type PKCz offered significant protection against PN and UVB-induced apoptosis (Figure 4 ). Such findings are basically consistent with the effect of PKC inhibitors as shown earlier ( Figure 1A and B) .
In order to obtain more quantitative data, we used another approach by analyzing DNA content/sub-G1 cells among those transfected cells ( Figure 5A ). Being consistent with the morphological changes, cells transfected with DN-PKCd or wild-type PKCz were resistant to PN and UVB-induced apoptotic cell death ( Figure 5B and C) . In contrast, overexpression of wild-type PKCd or DN-PKCz significantly enhanced cell death induced by PN and UVB treatment ( Figure 5B and C) . (A) Pre-treatment with a pan-specific PKC inhibitor (GF109203X); (B) pre-treatment with a specific PKCd inhibitor (rotterlin). JB6 cells were pre-treated with 5 mM PN for 2 h, 20 mM GF109203X or 1 mM rotterlin for 1 h and then subjected to 50 mJ/cm 2 of UVB. In some groups, cells were first pre-treated with GF109203X or rotterlin for 1 h, followed by PN and UVB. Apoptosis was quantified with DNA content/sub-G1 analysis 24 h after UVB irradiation. Data were presented in mean AE SD from three independent experiments. An asterisk indicates statistically significant comparison with the untreated control group (P 5 0.05). Figure 2 and harvested 30 min after UVB irradiation. Cell lysate was immunoprecipitated with anti-PKCs antibodies and then subjected to PKC kinase assay as described in Materials and methods. Data were quantified as described in Figure 2 .
Parthenolide and PKC in UVB-induced apoptosis
PKCz acts upstream of p38 MAPK but not JNK Our previous findings illustrated that the MAPK-AP-1 pathway is one of the molecular targets of PN (12) . Certain PKC isoforms have been shown to regulate the MAPK signaling cascade. For example, PKCd has been reported to affect the UVB-induced phosphorylations of Erk 1/2 and JNK (21) while PKCz primarily targets Erk 1/2 (25) . Since PKCs are known to respond differently depending on cell type and stimuli, we set out to identify the effect of PKCd and z on MAPK activation in our experimental system. Here we first confirmed our previous findings that PN pre-treatment is capable of blocking UVBinduced p38 activation, similar to the effect of a specific p38 inhibitor SB203580 ( Figure 6A ). Interestingly, pre-treatment with a pan-specific PKC inhibitor, GF109203X, inhibited the UVB-induced p38 activation to a certain extent, while the PKCd specific inhibitor, rotterlin, has no effect on p38 activation ( Figure 6A ). Next we examined the relationship between PKC and p38 activation using genetic approaches. When cells were transfected with wild-type or DN-PKCd, neither UVBinduced p38 activation nor the inhibitory effect of PN was affected as compared with the pcDNA-transfected control ( Figure 6B ). Intriguingly, overexpression of wild-type PKCz abolished the inhibitory effect of PN on UVB-induced Figure 6C ). Therefore, these data clearly suggest that it is PKCz, but not PKCd, that is responsible for UVB-induced p38 activation. Since PN is able to inhibit the phosphorylation of JNK induced by UVB as shown previously (12), here we also examined whether PKC has any functional role in UVBinduced JNK activation. As shown in Figure 7A , the two PKC inhibitors had no effect on UVB-induced JNK activation. Furthermore, overexpressions of the two DN forms of PKCd and PKCz had no effect on either UVB-induced JNK activation or the inhibitory effect of PN ( Figure 7B ). Unlike the previous findings (21, 25) , the total levels of MAPKs are not affected by the overexpressions of either the wildtype or DN forms of PKCd and PKCz. It is thus believed that UVB-induced JNK activation is independent of PKC activation.
In order to further confirm the functional linkage between PKCz and p38 activation in protection of apoptosis induced by PN and UVB, JB6 cells were transiently transfected with the wild-type PKCz together with DN-p38a and DN-p38b 2 plasmids. As shown in Figure 8A , overexpression of DN-p38a and DN-p38b 2 completely inhibited UVB-induced p38 activation. More importantly, while the overexpression of wild-type PKCz offered significant protection against apoptosis induced by PN-UVB, the co-transfection of the DN forms of p38 protein abolished the protective effect of wild-type PKCz and greatly sensitized cells to PN-UVB-induced apoptosis ( Figure 8B ). Such observations thus provide strong evidence that the anti-apoptotic function of PKCz is achieved via p38 activation and PN is likely to act through PKCz to suppress . Effect of PKC on p38 activation in UVB-treated cells. (A) PN and pan-specific PKC inhibitor GF109203X, but not the specific PKCd inhibitor rotterlin, inhibited UVB-induced p38 phosphorylation. Cells were pre-treated with 5 mM PN for 2 h, 20 mM GF109203X or 1 mM rotterlin for 1 h and then subjected to 50 mJ/cm 2 of UVB. (B) Overexpressions of wild-type (wt)-or DN forms of PKCd did not affect p38 activation induced by either UVB alone or PN plus UVB. (C) Overexpression of DN-PKCz blocked UVB-induced p38 activation and overexpression of wt-PKCz reversed the inhibitory effect of PN on UVB-induced p38 activation. JB6 cells were first transiently transfected with pcDNA, wt-or DN forms of PKCd or PKCz for 24 h, followed by treatment with PN and UVB. Cells were harvested 30 min after UVB irradiation. Thirty mg of cellular proteins were separated on 10% SDS-polyacrylamide gels and the subsequent membranes were hybridized with anti-p-p38, p38 and HA antibodies. The western blot data were collected and quantified as described in Figure 2 .
Parthenolide and PKC in UVB-induced apoptosis p38 activation, and then enhance apoptosis in UVB-treated JB6 cells.
Discussion
Even though the underlying mechanism(s) of the carcinogenic ability of UVB have not been fully understood, a number of molecular targets have been identified to be involved in UVB carcinogenesis, which include AP-1, NF-kB, NF-AT and STATs (16) (17) (18) (19) . We have previously shown that PN possesses a strong chemopreventive property against UVB-induced skin cancer via its potent inhibitory effect on the MAPK-AP-1 signaling pathway (12) . Here we further demonstrated that PN selectively regulates the activities of PKC: promotion of the pro-apoptotic PKCd and suppression of the pro-survival PKCz. Moreover, we also provided evidence that PN acts on PKCz upstream of p38 to sensitize UVB-induced apoptotic cell death. Thus, we reveal a new mechanism involved in the anticancer function of PN.
PKC can be classified into 11 isoforms based on the co-factors required for activation. UVB is known to activate certain PKC isoforms such as PKCd, e, z, l/i and h, leading to apoptosis or cell survival (21, 23, 25, 31) . It has been reported that UVB induces phospholipase A 2 activation and arachidonic acid release, and activates PKC (32) . Furthermore, UVB irradiation of cultured cells is also known to elevate levels of DAG (33) as well as to generate reactive oxygen radicals that may activate PKC (34) . Among all the UVB-activated PCK isoforms, PKCd seems to be the main subtype involved in apoptotic signaling induced by various stimuli including UVB (22) . It is generally believed that activated PKCd decreases mitochondrial membrane potential, resulting in cytochrome c release, caspase activation and apoptosis (22) . On the other hand, PKCz has been shown to promote cell survival by either stimulating the nucleotide excision repair activity (35) or phosphorylating Rel A and subsequently activating the NF-kB survival pathway (36) .
One important observation of this study is the differential effect by PN on different PKC isoforms in cells treated with UVB: PN selectively enhances the pro-apoptotic PKCd and suppresses the anti-apoptotic PKCz (Figures 2 and 3) . Indeed, selective effects on different PKC isoforms have been reported previously. Sodium butyrate has been shown to upregulate PKCe while downregulating PKCb during erythroid differentiation (37) . UCN-01, a staurosporine analog, has been illustrated to have selective effect on different PKC isoforms used in vitro kinase assay (38) . In addition, a diazene carbonyl derivative diamide, which oxidizes thiols to disulfides through addition/displacement reactions at the diazene bond, stimulates the pro-apoptotic PKCd while inactivating the oncogenic PKCe (39) .
The selective regulation on PKCd and PKCz can also be appreciated by the difference in their molecular structures. Although both PKCs contain an N-terminal regulatory domain and a C-terminal catalytic kinase domain, PKCd contains two cysteine-rich C1 subdomains (40) whereas PKCz has only one zinc finger binding region (41) . DAG is known to bind to one of the cysteine-rich C1 subdomains and activate PKCd. In contrast, PKCz is regulated by other lipid co-factors such as phosphatidylinositol (PI) 3,4,5-P 3 and ceramide (42) . The exact mechanisms responsible for the differential regulation of PN on UVB-induced PKC activation are currently not known. One possible explanation is related to the involvement of the caspase cascade in PKC activation. For instance, PKCd is cleaved by caspase-3 during apoptosis to a more catalytically active fragment (43) . In contrast, caspase-3-dependent cleavage of PKCz generates a fragment that corresponds to its catalytic domain and is enzymatically inactive (24) . Since PN is a potent activator of caspase-3 (8,9), it is possible that 
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both PKCd and PKCz were cleaved by caspase-3 in response to PN-UVB treatment. As a result, the catalytically active PKCd and the inactive fragment of PKCz are generated, leading to more profound cell death induced by PN-UVB.
Currently, there is still controversy with regard to the exact role of JNK and p38 in UV-induced apoptosis, with both proand anti-apoptotic activities being reported (44) (45) (46) . Our previous findings indicated that PN sensitizes UVB-induced apoptosis by inhibiting both JNK and p38, leading to blockade in the pro-survival AP-1 pathway (12) . The link between MAPK and PKC has been reported previously. Chen et al. (21) showed that PKCd and PKCe mediate UVB-induced signal transduction and apoptosis through the activation of ERK and JNK. Furthermore, inhibition of PKCl/i with a dominant negative mutant suppressed UVB-induced ERK and the subsequent AP-1 activation (47) . On the other hand, the antisense oligonucleotide of PKCz has been shown to inhibit UVB-induced AP-1 activation (25) . In this study, we provide convincing evidence suggesting that PKCz acts upstream of p38, but not JNK, to protect cell death induced by PN-UVB, based on experimental data using both pharmacological and genetic approaches. For instance, overexpression of wide-type PKCz reverses the inhibitory effect of PN on UVB-induced p38 phosphorylation ( Figure 6C) , and transfections with wild-type PKCz together with DN-p38a and DN-p38b 2 plasmids completely abolishing the protective effect of wild-type PKCz and greatly sensitizes cells to PN-UVB-induced apoptosis ( Figure 8B ). Therefore, it is clear that the sensitization activity of PN on UVB-induced apoptosis is probably achieved through its inhibitory effect on the PKCz and p38 signaling pathway.
In summary, we show for the first time that PN sensitizes JB6 cells to UVB-induced apoptosis through selective regulation on the pro-apoptotic PKCd and the pro-survival PKCz functions. Furthermore, our data also suggest that the UVBinduced p38 MAPK activation is regulated via a PKCzdependent mechanism. These findings may shed new light in understanding the anticancer activity of PN. ). Cells were harvested 30 min after UVB irradiation. Thirty mg of cellular proteins were separated on 10% SDS-polyacrylamide gels and the subsequent membranes were hybridized with anti-p-p38, p38 and Flag antibodies. (B) Overexpressions of DN-p38a and DN-p38b 2 completely abolished the protective effect of wilt-type (wt)-PKCz on apoptosis induced by PN and UVB. Cells were transfected with wt-PKCd, with or without DN-p38a and DN-p38b 2 for 24 h, followed by treatment with PN and UVB. Cells were collected for DNA content analysis for sub-G1 cells 24 h after UVB irradiation. Data were presented in mean AE SD from three independent experiments. An asterisk indicates statistically significant comparison with the group transfected with pcDNA only (P 5 0.05).
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